|
Volumn 14, Issue 3, 2008, Pages 431-432
|
Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCIUM;
INTERLEUKIN 1;
INTERLEUKIN 11;
INTERLEUKIN 1ALPHA;
INTERLEUKIN 1BETA;
INTERLEUKIN 2;
INTERLEUKIN 6;
OSTEOCALCIN;
OSTEOCLAST DIFFERENTIATION FACTOR;
OSTEOPROTEGERIN;
PARATHYROID HORMONE;
PHOSPHATE;
RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;
TUMOR NECROSIS FACTOR ALPHA;
ADULT;
BLOOD ANALYSIS;
BLOOD SAMPLING;
BONE MARROW CELL;
BONE REMODELING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DIET RESTRICTION;
DISEASE ASSOCIATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
IMMUNOFLUORESCENCE TEST;
LETTER;
MALE;
MULTIPLE SCLEROSIS;
OSTEOBLAST;
OSTEOCLAST;
OSTEOLYSIS;
PROBABILITY;
PROTEIN EXPRESSION;
PROTEIN SYNTHESIS;
RANK SUM TEST;
STORAGE TEMPERATURE;
T LYMPHOCYTE ACTIVATION;
ADULT;
BONE REMODELING;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MULTIPLE SCLEROSIS;
OSTEOPROTEGERIN;
RANK LIGAND;
RISK FACTORS;
|
EID: 43549093518
PISSN: 13524585
EISSN: None
Source Type: Journal
DOI: 10.1177/1352458507084028 Document Type: Letter |
Times cited : (22)
|
References (10)
|